JP Morgan Chase’s Zura Bio ZURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$25.3M Sell
4,458,851
-13,905
-0.3% -$84K ﹤0.01% 1890
2025
Q4
$23.4M Sell
4,472,756
-151,443
-3% -$599K ﹤0.01% 1929
2025
Q3
$20M Sell
4,624,199
-35,752
-0.8% -$64.3K ﹤0.01% 2101
2025
Q2
$4.89M Buy
4,659,951
+2,052,732
+79% +$2.45M ﹤0.01% 3193
2025
Q1
$3.36M Sell
2,607,219
-25,966
-1% -$41K ﹤0.01% 3488
2024
Q4
$6.58M Buy
2,633,185
+2,611,532
+12,061% +$9.3M ﹤0.01% 3099
2024
Q3
$87.9K Sell
21,653
-3,151
-13% -$11.8K ﹤0.01% 5754
2024
Q2
$86.8K Buy
24,804
+17,520
+241% +$71.4K ﹤0.01% 5601
2024
Q1
$18.7K Sell
7,284
-4,946
-40% -$17.5K ﹤0.01% 6241
2023
Q4
$57.1K Buy
12,230
+4,411
+56% +$22.1K ﹤0.01% 5958
2023
Q3
$51.6K Buy
7,819
+1,776
+29% +$11.9K ﹤0.01% 5799
2023
Q2
$49.6K Buy
+6,043
New +$48.5K ﹤0.01% 5725

Other funds holding ZURA

JP Morgan Chase's ZURA Position: Q1 2026 in Review

JP Morgan Chase reduced its Zura Bio (ZURA) stake by 0.31% in Q1 2026, selling an estimated $84K and leaving 4,458,851 shares worth $25.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1890.

JP Morgan Chase first reported a position in ZURA in Q2 2023 and has held it in 12 quarters since. 94 funds tracked by Wall St. Rank hold ZURA as of Q1 2026.

  • JP Morgan Chase held 4,458,851 shares of Zura Bio worth $25.3M as of Q1 2026.
  • JP Morgan Chase sold 13,905 Zura Bio shares in Q1 2026, an estimated $84K.
  • Zura Bio made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #1890 holding.
  • JP Morgan Chase first reported a position in Zura Bio in Q2 2023 and has held it in 12 quarters since.
  • 94 funds tracked by Wall St. Rank held Zura Bio as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.